from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1843c/guaB1

LFCtreatmentdescriptionclass of inhibitor

-1.854

Amikacinug/mL Amikacintranslation

-2.342

Cap5-10ug/mL Capreomycintranslation

-3.770

Rox10-50 ug/mL Roxithromycintranslation

-0.542

SM2-5 ug/mL Streptomycintranslation

-2.216

Tet5-10 ug/mL Tetracyclinetranslation

-0.397

Rif0.2-5ug/mL Rifampicintranscription

0.464

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.437

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.122

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.281

CPZ10-50 ug/mL Chlorpromazinerespiration

1.449

Clofazimine10-13 ug/mL Clofaziminerespiration

0.557

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.475

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.274

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.420

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.770

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.946

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.431

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.801

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.343

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.137

KCN5-20 ug/mL Potassium cyaniderespiration

0.289

NaN30.2-2 mM Sodium aziderespiration

1.229

Nigericin50 uM Nigericinrespiration

0.207

TRC10-150 ug/mL Triclosanrespiration

0.648

TRZ10-25 ug/mL Thioridazinerespiration

-1.371

Valinomycin0.5-10 uM Valinomycinrespiration

0.298

ZnSO42 mM ZnSO4respiration

0.457

menadione6-10 ug/mL Menadionerespiration

0.453

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.071

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.073

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.763

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.306

NRP_1Non-replicating persistence stage 1dosRassociated

0.157

Amp0.2mg/mL AmpicillincellWall

-0.239

Cephalexin20-100 ug/mL CephalexincellWall

-0.030

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.221

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.373

EMB10-20 ug/mL EthambutolcellWall

1.037

Eta12-40 ug/mL EthionamidecellWall

0.590

INH0.2-0.4 ug/mL IsoniazidcellWall

0.241

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.140

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.110

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.860

BZA0.12 mg/mL BenzamidearomaticAmides

-0.653

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.689

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.330

H2O24 mM hydrogen peroxideDNAdamaging

-0.759

Levo10 ug/mL LevofloxacinDNAdamaging

-0.493

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.413

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.313

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.676

UVUV-irradiationDNAdamaging

0.825

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.271

Antimycin12.5-50 ug/mL Antimycin A?

-0.116

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.022

PA_110-50 ug/mL Antitubercular compound PA-1?

0.041

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.995

PA8240.2-2 ug/mL PA-824?

0.278

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.038

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.196

Verapamil50 uM Verapamil?

-0.490

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.486

methoxatin10-20 ug/mL Methoxatin?